Clavaric acid
Clavaric acid is a triterpenoid produced by the mushroom Hypholoma sublateritium. Clavaric acid was discovered by Merck Research Laboratories in a random screening of natural extracts. Clavaric acid is a reversible farnesyltransferase inhibitor with an IC50 of 1.3 μM.[1][2]
 | |
| Names | |
|---|---|
| Other names
24, 25-Dihydroxy-2-(3-hydroxy-3-methylglutaryl)lanostan-3-one | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C36H58O8 | |
| Molar mass | 618.852 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
References
- Lingham RB, Silverman KC, Jayasuriya H, Kim BM, Amo SE, Wilson FR, et al. (1998). "Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase". J Med Chem. 41 (23): 4492–501. doi:10.1021/jm980356+. PMID 9804689.
- Godio RP, Fouces R, Martín JF (2007). "A squalene epoxidase is involved in biosynthesis of both the antitumor compound clavaric acid and sterols in the basidiomycete H. sublateritium". Chem Biol. 14 (12): 1334–46. doi:10.1016/j.chembiol.2007.10.018. PMID 18096502.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.